Aging and cancer: The double-edged sword of replicative senescence

Journal of the American Geriatrics Society

Volumn 45, Issue 4, 1997, Pages 482-488

  Campisi, Judith ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

CANCER; CARCINOGENESIS; CELL AGING; CELL DIFFERENTIATION; MOLECULAR BIOLOGY; PHENOTYPE; REVIEW; SENESCENCE;

EID: 0030887851     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1997.tb05175.x     Document Type: Review

References (52)

1. Finch CE. Longevity, Senescence, and the Genome. Chicago: University of Chicago Press, 1990.
2. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965;37:614-636.
3. Stanulis-Praeger B. Cellular senescence revisited: A review. Mech Ageing Dev 1987;38:1-48.
4. Campisi J, Dimri GP, Hara E. Control of replicative senescence. In: Handbook of the Biology of Aging. Schneider E, Rowe J, eds. New York: Academic Press, 1996, pp 121-149.
5. Sager R. Resistance of human cells to oncogenic transformation. Cancer Cells 1984;2:487-493.
6. McCormick JJ, Maher VM. Towards an understanding of the malignant transformation of diploid human fibroblasts. Mutat Res 1988;199:273-291.
7. Shay JW, Wright WR. Defining the molecular mechanisms of human cell immortalization. Biochim Biophys Acta 1991;1071:1-7.
8. Levy MZ, Allsopp RC, Futcher AB et al. Telomere end-replication problem and cell aging. J Mol Biol 1992;225:951-960.
9. Harley CB, Villeponteau B. Telomeres and telomerase in aging and cancer. Curr Opinion Genet Dev 1995;5:249-255.
10. Tommerup H, Dousmanis A, De Lange T. Unusual chromatin in human telomeres. Mol Cell Biol 1994;14:5777-5785.
11. Blackburn EH. Structure and function of telomeres. Nature 1991;350:569-573.
12. Shay JW, Werbin H, Wright WE. You haven't heard the end of it: Telomere loss may link human aging with cancer. Can J Aging 1995;14:511-524.
13. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990;345:458-460.
14. Allsopp RC, Vaziri H, Patterson C et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992;89:10114-10118.
15. Hornsby PJ, Aldern KA, Harris SE. Clonal variation in response to adrenocorticotropin in cultured bovine adrenocortical cells: Relationship to senescence. J Cell Physiol 1986;129:395-402.
16. Rittling SR, Brooks KM, Cristofalo VJ, Baserga R. Expression of cell cycle dependent genes in young and senescent W138 fibroblasts. Proc Natl Acad Sci USA 1986;83:3316-3320.
17. Seshadri T, Campisi J. c-fos repression and an altered genetic program in senescent human fibroblasts. Science 1990;247:205-209.
18. Chang ZF, Chen KY. Regulation of ornithine decarboxylase and other cell-cycle dependent genes during senescence of IMR90 human fibroblasts. J Biol Chem 1988;263:11431-11435.
19. Phillips PD, Pignolo RJ, Nishikura K, Cristofalo VJ. Renewed DNA synthesis in senescent W138 cells by expression of an inducible chimeric c-fos construct. J Cell Physiol 1992;151:206-212.
20. Wang E. Senescent human fibroblasts resist programmed cell death and failure to suppress bcl2 is involved. Cancer Res 1995;55:2284-2292.
21. Goldstein S. Replicative senescence: The human fibroblast comes of age. Science 1990;249:1129-1133.
22. Hara E, Yamaguchi T, Nojima H et al. Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. J Biol Chem 1994;269:2139-2145.
23. Dimri GP, Hara E, Campisi J. Regulation of two E2F-related genes in presenescent and senescent human fibroblasts. J Biol Chem 1994;269:16180-16186.
24. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995;9:1149-1163.
25. Noda A, Ning Y, Venable SF et al. Cloning of senescent cell derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994;211:90-98.
26. Hara E, Smith R, Parry D et al. Regulation of p16 (CdkN2) expression and its implications for cell immortalization and senescence. Mol Cell Biol 1996;16:859-867.
27. Dimri GP, Nakanishi M, Desprez PY et al. Inhibition of E2F activity by the p21 inhibitor of cyclin-dependent protein kinases in cells expressing or lacking a functional retinoblastoma protein. Mol Cell Biol 1996;16:2987-2997.
28. Stein GH, Drullinger LF, Robetorye RS et al. Senescent cells fail to express cdc2, cycA and cycB in response to mitogen stimulation. Proc Natl Acad Sci USA 1991;88:11012-11016.
29. Good LF, Dimri GP, Campisi J, Chen KY. Regulation of dihydrofolate reductase gene expression and E2F components in human diploid fibroblasts during growth and senescence. J Cell Physiol 1996;168:580-588.
30. Hara E, Uzman JA, Dimri GP, Nehlin JO, Testori A, Campisi J. The helix-loop-helix protein Id-1 and a retinoblastoma protein binding mutant of SV40 T antigen synergize to reactivate DNA synthesis in senescent human fibroblasts. Dev. Genetics 1996;18:161-172.
31. Maier JAM, Voulalas P, Roeder D, Maciag T. Extension of the life-span of human endothelial cells by an interleukin-la antisense oligomer. Science 1990;249:1570-1574.
32. Maier JAM, Statuto M, Ragnoti G. Senescence stimulates U037-endothelial cell interactions. Exp Cell Res 1993;208:270-274.
33. Swisshelm K, Ryan K, Lee X et al. Down-regulation of retinoic acid receptor b in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth Differ 1994;5:133-141.
34. Saunders NA, Smith RJ, Jetten AM. Regulation of proliferation-specific and differentiation-specific genes during senescence of human epidermal keratinocytes and mammary epithelial cells. Biochim Biophys Res Commun 1994;197:46-54.
35. Cheng CY, Ryan RF, Vo TP, Hornsby PJ. Cellular senescence involves stochastic processes causing loss of expression of differentiated functions: SV40 as a means for dissociating effects of senescence on growth and on differentiated function gene expression. Exp Cell Res 1989;180:49-62.
36. West MD, Pereira-Smith OM, Smith JR. Replicative senescence of human skin fibroblasts correlates with a loss of regulation and overexpression of collagenase activity. Exp Cell Res 1989;184:138-137.
37. Millis AJ, Hoyle M, McCue HM, Martini H. Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts. Exp Cell Res 1992;201:373-379.
38. Wick M, Burger C, Brusselbach S et al. A novel member of human tissue inhibitor of metalloproteinases (TIMP) gene family is regulated during G1 progression, mitogenic stimulation, differentiation and senescence. J Biol Chem 1994;269:18953-18960.
39. Newbold RF, Overell RW, Connell JR. Induction of immortality is an early event in malignant transformation of mammalian cells by carcinogens. Nature 1982;299:633-635.
40. Sager R. Senescence as a mode of tumor suppression. Environ Health Persp 1991;93:59-62.
41. Dimri GP, Campisi J. Molecular and cell biology of replicative senescence. Cold Spring Harbor Symp on Quant Biol. Mol Genet Cancer 1994;59:67-73.
42. Yu CE, Oshima J, Fu YH et al. Positional cloning of the Werner's syndrome gene. Science 1996;272:258-262.
43. Dimri GP, Lee X, Basile G et al. A novel biomarker identifies senescent human cells in culture and aging skin in vivo. Proc Natl Acad Sci USA 1995;92:9363-9367.
44. Effros RB. Insights on immunological aging derived from the T lymphocyte cellular senescence model. Exp Gerontol 1996;31:21-27.
45. Miller RA. Gerontology as oncology: Research on aging as a key to the understanding of cancer. Cancer 1991;68:2496-2501.
46. Renan MJ. How many mutations are required for tumorigenesis? Implications from human cancer data. Mol Carcinog 1993;7:139-146.
47. Bishop JM. Cancer - The rise of the genetic paradigm. Genes & Dev 1995;9:1309-1315.
48. Lochter A, Bissell MJ. Involvement of extracellular matrix constituents in breast cancer. Sem Cancer Biol 1995;6:165-173.
49. Fidler IJ. Modulation of the organ microenvironment for treatment of cancer metastasis. J Natl Cancer Inst 1995;87:1588-1592.
50. Lupu R, Cardillo M, Harris L et al. Interaction between erbB receptors and heregulm in breast cancer tumor progression and drug resistance. Sem Cancer Biol 1995;6:135-145.
51. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87:2095-2147.
52. Pili R, Guo Y, Chung J et al. Altered angiogenesis underlying age-dependent changes in tumor growth. J Natl Canc Inst 1994;86:1303-1314.